Диссертация (1140958), страница 18
Текст из файла (страница 18)
R. Relationship ofsalivary cortisol and anxiety in recurrent aphthous stomatitis. Indian J EndocrinolMetab. 2015 Jan-Feb; 19(1): 56–59. doi: 10.4103/2230-8210.131768.176. Nakatani D., Sato H., Sakata Y., et al. Influence of serotonin transporter genepolymorphism on depressive symptoms and new cardiac events after acutemyocardial infarction. Am Heart J. 2005;150:652-658177.
Nau F., Yu B., Martin D., Nichols C.D. Serotonin 5-HT2A receptor activationblocks TNF-α mediated inflammation in vivo. PLoS One. 2013 Oct2;8(10):e75426.178. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic andprognostic factor in coronary heart disease: a meta-analysis of 6362 events among146 538 participants in 54 observational studies. Eur Heart J. 2006;27:2763–2774.106179.
Nishihira K, Yamashita A, Tanaka N, Kawamoto R, Imamura T, YamamotoR, Eto T, Asada Y. Inhibition of 5-hydroxytryptamine receptor prevents occlusivethrombusformation on neointima of the rabbit femoral artery. J Thromb Haemost.2006 Jan;4(1):247-55.180. Nomura M., Kusumi I., Kaneko M., Masui T., Daiguji M., Ueno T., KoyamaT., Nomura Y. Involvement of a polymorphism in the 5-HT2A receptor gene inimpulsive behavior. Psychopharmacology (Berl). 2006 Jul;187(1):30-5.181. Nomura M., Nomura Y.
Psychological, neuroimaging, and biochemicalstudies on functional association between impulsive behavior and the 5-HT2Areceptor gene polymorphism in humans. Ann N Y Acad Sci. 2006 Nov;1086:13443.182. Ogawa, T., Sugidachi, A., Tanaka, N., Fujimoto, K., Asai, F., 2002.Pharmacological profiles of R-96544, the active form of a novel 5-HT2A receptorantagonist R-102444. Eur. J. Pharmacol. 457, 107–114.183. O'Malley P.G., Jones D.L., Feuerstein I.M., Taylor A.J. Lack of correlationbetween psychological factors and subclinical coronary artery disease. N Engl JMed.
2000;343:1298–1304.184. Oswald P., Souery D., Massat I., Del-Favero J., Linotte S., Papadimitriou G.,Dikeos D., Kaneva R., Milanova V., Oruc L., Ivezic S., Serretti A., Lilli R., VanBroeckhoven C., Mendlewicz J. Lack of association between the 5HT2A receptorpolymorphism (T102C) and unipolar affective disorder in a multicentric Europeanstudy.Eur Neuropsychopharmacol.
2003 Oct;13(5):365-8.185. Otte C., McCaffery J., Ali S., Whooley M.A. Association of a serotonintransporter polymorphism (5-HTTLPR) with depression, perceived stress, andnorepinephrine in patients with coronary disease: the Heart and Soul Study. Am JPsychiatry. 2007 Sep;164(9):1379-84.186. Pang-Hsiang Liu, Fu-Chang Hu, Jung-Der Wang. Differential risks of strokein pharmacotherapy on uncomplicated hypertensive patients? Journal ofHypertension 2009, 27:174–180107187. Parker RS, Lewis GN, Rice DA, McNair PJ. Is Motor Cortical ExcitabilityAltered in People with Chronic Pain? A Systematic Review and Meta-Analysis.BrainStimul.2016Apr4.pii:S1935-861X(16)30050-X.doi:10.1016/j.brs.2016.03.020.188.
Parsons MJ, D'Souza UM, Arranz MJ, Kerwin RW, Makoff AJ. The 1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affectspromoter activity. Biol Psychiatry. 2004 Sep 15;56(6):406-10189. Patterson CM, Kosson DS, Newman JP (1987) Reaction to punishment,reflectivity, and passive avoidance learning in extraverts. J Pers Soc Psychol52:565–575190. Pawlak D, Pawlak K, Chabielska E, Małyszko J, Takada A, Myśliwiec M,Buczko W. A potent 5-hydroxytryptamine receptor (5-HT2A) antagonist, DV7028, delays arterial thrombosis development in rats. Thromb Res. 1998 Jun15;90(6):259-70.191.
Peñas-Lledó EM, Dorado P, Cáceres MC, de la Rubia A, Llerena A.Association between T102C and A-1438G polymorphisms in the serotoninreceptor 2A (5-HT2A) gene and schizophrenia: relevance for treatment withantipsychotic drugs. Clin Chem Lab 53. Med. 2007;45(7):835-8.192. Peremans K., Audenaert K., Coopman F., Blanckaert P., Jacobs F., Otte A.,Verschooten F., van Bree H., van Heeringen K., Mertens J., Slegers G., Dierckx R.Estimates of regional cerebral blood flow and 5-HT2A receptor density inimpulsive, aggressive dogs with 99mTc-ECD and 123I-5-I-R91150.
Eur J NuclMed Mol Imaging. 2003 Nov;30(11):1538-46.193. Peremans K., Audenaert K., Hoybergs Y., Otte A., Goethals I., Gielen I.,Blankaert P., Vervaet M., van Heeringen C., Dierckx R. The effect of citalopramhydrobromide on 5-HT2A receptors in the impulsive-aggressive dog, as measuredwith 123I-5-I-R91150 SPECT.
Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):70816.108194. Picco L., Subramaniam M., Abdin E., Vaingankar JA., Chong SA. Genderdifferences in major depressive disorder: findings from the Singapore MentalHealth Study. Singapore Med J. 2016 Aug 16. doi: 10.11622/smedj.2016144195.
Plomin R., Scheier M.F., Bergeman C.S., Pedersen N.L., Nesselroade J.R.,McClearn G.E. Optimism, pessimism and mental health: A twin/adoption analysis.Personality and Individual Differences. 1992;13(8):921–930.196. Polesskaya O.O., Aston, C., & Sokolov, B. P. (2006). Allele C-specificmethylation of the 5-HT2A receptor gene: Evidence for correlation with itsexpression and expression of DNA methylase DNMT1. Journal of NeuroscienceResearch, 83, 362–373.197.
Pope J.H., Ruthazer R., Beshansky J.R., Griffith J.L., Selker H.P. Clinicalfeatures of emergency department patients presenting with symptoms suggestive ofacute cardiac ischemia: A multicenter study. Journal of Thrombosis andThrombolysis. 1998;6:63–74.198. Pope M.L., Smith T.W. Cortisol excretion in high and low cynically hostilemen. Psychosom Med. 1991;53:386–392.199. Popova N.K., Naumenko V.S., Kozhemyakina R.V., Plyusnina I.Z.Functional characteristics of serotonin 5-HT2A and 5-HT2C receptors in the brainand the expression of the 5-HT2A and 5-HT2C receptor genes in aggressive andnon-aggressive rats.
Neurosci Behav Physiol. 2010 May;40(4):357-61.200. Pratt L.A., Ford D.E., Crum R.M., Armenian H.K., Gallo J.J., Eaton W.W.Depression, psychotropic medication, and risk of myocardial infarction:prospective data from the Baltimore ECA follow-up. Circulation. 1996;94:3123–3129.201. Progovac., Ana. The genetic link between depression and cardiovasculardisease. In Neuroscience Submitted April 2010.202. Ramos Neto ES, Mágulas JO, Sousa JJ, Moura AC , Pinto GR, Yoshioka FK, Canalle R, Motta FJ.
Study of polymorphic variants of the serotonin 2A receptorgene (5-HT2A) and its possible effects on smoking habits of a population from109northeasternBrazil.GenetMolRes. 2014Oct20;13(4):8268-77.doi:10.4238/2014.October.20.3.203. Reid G.J., Seidelin P.H., Kop W.J., Irvine M.J., Strauss B.H., Nolan R.P., LauH.K., Yeo E.L. Mental-stress-induced platelet activation among patients withcoronary artery disease. Psychosom Med. 2009 May;71(4):438-45. doi:10.1097/PSY.0b013e31819cc751. Epub 2009 Feb 27.204.
Reimold M., Knobel A., Rapp MA., Batra A., Wiedemann K., Ströhle A.,Zimmer A., Schönknecht P., Smolka M.N., Weinberger DR., Goldman D.,Machulla HJ., Bares R.,Heinz A. Central serotonin transporter levels are associatedwith stress hormone response and anxiety. Psychopharmacology (Berl). 2011Feb;213(2-3):563-72.205. Rich M.W., Saini J., Kleiger R.E., Carney R.M., TeVelde A., Freedland K.E.Correlation of heart rate variability with clinical and angiographic variables andlate mortality after coronary angiography. Am J Cardiol. 1988;62:59–66.206.
Risch N., Herrell R., Lehner T., Kung-Yee Liang, Eaves L., Hoh J., Griem A.,Kovacs M., Ott J., Merikangas K. Interaction Between the Serotonin TransporterGene (5-HTTLPR), Stressful Life Events, and Risk of Depression. JAMA. Jun 17,2009; 301(23): 2462–2471.207. Roest A.M., Martens E.J., de Jonge P., Denollet J. Anxiety and risk ofincident coronary heart disease: a meta-analysis. J Am Coll Cardiol. 2010 Jun29;56(1):38-46.208. Rosell D.R., Thompson J.L., Slifstein M., Xu X., Frankle W.G., New A.S.,Goodman M., Weinstein S.R., Laruelle M., Abi-Dargham A., Siever L.J.
Increasedserotonin 2A receptor availability in the orbitofrontal cortex of physicallyaggressivepersonalitydisorderedpatients.BiolPsychiatry.2010Jun15;67(12):1154-62.209. Rosell D.R., Thompson J.L., Slifstein M., Xu X., Frankle W.G., New A.S.,Goodman M., Weinstein S.R., Laruelle M., Abi-Dargham A., Siever L.J. Increasedserotonin 2A receptor availability in the orbitofrontal cortex of physically110aggressivepersonalitydisorderedpatients.BiolPsychiatry.2010Jun15;67(12):1154-62.210.
Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almahmeed WA,Blackett KN, Shitti-amorn C, Sato H, Yusuf S. Association of psychosocial riskfactors with risk of acute myocardial infarction in 11119 cases and 13648 controlsfrom 52 countries (the INTERHEART study): case-control study. Lancet.2004;364:953–962.doi:10.1016/S0140-6736(04)17019-0211. Rutledge T., Hogan B.E. A quantitative review of prospective evidencelinking psychological factors with hypertension development. Psychosom Med.2002 Sep-Oct;64(5):758-66.212. Rutledge T., Kenkre Т.S., Bittner V., Krantz D.
S., Thompson D. V., LinkeJo-Ann Eastwood S. E., Eteiba W., Cornell C. E., Vaccarino V., Pepine C. J.,Johnson B. D., Merz C. N.Anxiety Associations with Cardiac Symptoms,Angiographic Disease Severity, & Healthcare Utilization: The NHLBI-SponsoredWomen’s Ischemia Syndrome Evaluation. Int J Cardiol. 2013 Oct 3; 168(3): 2335–2340. Published online 2013 Feb 12.doi: 10.1016/j.ijcard.2013.01.036213. Rutledge T., Linke S.E., Krantz D.S., Johnson B.D., Bittner V., Eastwood JA,Eteiba W, Pepine CJ, Vaccarino V,Francis J, Vido DA, Merz CN. Comorbiddepression and anxiety symptoms as predictors of cardiovascular events: resultsfrom the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)study.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
